Literature DB >> 10355650

Primary thymic epithelial neoplasms: spectrum of differentiation and histological features.

S Suster1, C A Moran.   

Abstract

Primary thymic epithelial neoplasms have been the source of much controversy over the years because of difficulties in their histopathologic classification and prognostication of clinical behavior. Despite recent advances in our understanding of the immunopathology and molecular pathology of these neoplasms, no universally accepted system of classification is yet available for these tumors. A variety of classification schemes have been proposed in the past based on either morphological, histogenetic, or immunophenotypic considerations. For the most part, the majority of such classifications have been merely descriptive with little value for prognostication, or have proven cumbersome and difficult to apply in clinical practice. Recent studies have shown that primary thymic epithelial neoplasms, rather than representing several discrete, separate entities constitute part of a continuous spectrum of differentiation ranging from well-differentiated neoplasms to poorly-differentiated neoplasms. Based on these observations, a novel classification of primary thymic epithelial neoplasms has been proposed that divides these tumors into three easily reproducible diagnostic categories based on their degrees of differentiation: thymoma, atypical thymoma, and thymic carcinoma (corresponding to well-differentiated, moderately-differentiated, and poorly-differentiated neoplasms, respectively). The histopathologic features and diagnostic criteria for these tumors is the subject of this review.

Entities:  

Mesh:

Year:  1999        PMID: 10355650

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  7 in total

1.  The World Health Organization (WHO) histologic classification of thymomas: a reanalysis.

Authors:  Cesar A Moran; Saul Suster
Journal:  Curr Treat Options Oncol       Date:  2009-02-04

2.  Neoplastic transformation and angiogenesis in the thymus of transgenic mice expressing SV40 T and t antigen under an L-pyruvate kinase promoter (SV12 mice).

Authors:  Bernadette Nabarra; Christiane Pontoux; Cecile Godard; Mary Osborne-Pellegrin; Sophie Ezine
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

Review 3.  Cerebral involvement of metastatic thymic carcinoma.

Authors:  Doo-Sik Kong; Jung-Il Lee; Do Hyun Nam; Keunchil Park; Yeon-Lim Suh
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

Review 4.  Diagnosis of thymoma.

Authors:  S Suster
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

5.  Atypical thymomas with squamoid and spindle cell features: clinicopathologic, immunohistochemical and molecular genetic study of 120 cases with long-term follow-up.

Authors:  David I Suster; A Craig Mackinnon; Marcello DiStasio; Malay Kumar Basu; German Pihan; Saul Suster
Journal:  Mod Pathol       Date:  2022-02-10       Impact factor: 8.209

6.  Diagnostic reproducibility of thymic epithelial tumors using the World Health Organization classification: note for thoracic clinicians.

Authors:  Noriaki Sakakura; Hisashi Tateyama; Shigeo Nakamura; Tetsuo Taniguchi; Noriyasu Usami; Yoshinori Ishikawa; Koji Kawaguchi; Kohei Yokoi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-12-12

7.  Deciphering tissue-based proteome signatures revealed novel subtyping and prognostic markers for thymic epithelial tumors.

Authors:  Xin Ku; Qiangling Sun; Lei Zhu; Zhitao Gu; Yuchen Han; Ning Xu; Chen Meng; Xiaohua Yang; Wei Yan; Wentao Fang
Journal:  Mol Oncol       Date:  2020-02-06       Impact factor: 6.603

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.